<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36893588</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Cytotoxic CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells contribute to the pathogenesis of systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>104507</StartPage><MedlinePgn>104507</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104507</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2023.104507</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(23)00072-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease affecting multiple organs and tissues with high cellular heterogeneity. CD8<sup>+</sup> T cell activity is involved in the SLE pathogenesis. However, the cellular heterogeneity and the underlying mechanisms of CD8<sup>+</sup> T cells in SLE remain to be identified.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single-cell RNA sequencing (scRNA-seq) of PBMCs from a SLE family pedigree (including 3&#xa0;HCs and 2 SLE patients) was performed to identify the SLE-associated CD8<sup>+</sup> T cell subsets. Flow cytometry analysis of a SLE cohort (including 23&#xa0;HCs and 33 SLE patients), qPCR analysis of another SLE cohort (including 30&#xa0;HCs and 25 SLE patients) and public scRNA-seq datasets of autoimmune diseases were employed to validate the finding. Whole-exome sequencing (WES) of this SLE family pedigree was used to investigate the genetic basis in dysregulation of CD8<sup>+</sup> T cell subsets identified in this study. Co-culture experiments were performed to analyze the activity of CD8<sup>+</sup> T cells.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">We elucidated the cellular heterogeneity of SLE and identified a new highly cytotoxic CD8<sup>+</sup> T cell subset, CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cell subpopulation, which was remarkably increased in SLE patients. Meanwhile, we discovered a close correlation between mutation of DTHD1 and the abnormal accumulation of CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells in SLE. DTHD1 interacted with MYD88 to suppress its activity in T cells and DTHD1 mutation promoted MYD88-dependent pathway and subsequently increased the proliferation and cytotoxicity of CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells. Furthermore, the differentially expressed genes in CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells displayed a strong out-of-sample prediction for case-control status of SLE.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">This study identified DTHD1-associated expansion of CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cell subpopulation is critical for SLE. Our study highlights genetic association and cellular heterogeneity of SLE pathogenesis and provides a mechanistical insight into the diagnosis and treatment of SLE.</AbstractText><AbstractText Label="FUNDINGS" NlmCategory="RESULTS">Stated in the Acknowledgements section of the manuscript.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Mintian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Ni</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Jiongjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiuting</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dongyang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Emergency Medicine and Critical Care, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Ziqi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cen</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Guozhen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huai</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200127, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China. Electronic address: guoqingzsy@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Translational Medical Center for Stem Cell Therapy, Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200127, China; Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China. Electronic address: chenk@tongji.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053594" MajorTopicYN="N">Myeloid Differentiation Factor 88</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013602" MajorTopicYN="N">T-Lymphocytes, Cytotoxic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8(+) T cell subset</Keyword><Keyword MajorTopicYN="N">DTHD1</Keyword><Keyword MajorTopicYN="N">Genetic variant</Keyword><Keyword MajorTopicYN="N">MYD88</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Whole-exome sequencing</Keyword><Keyword MajorTopicYN="N">scRNA-seq</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>18</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36893588</ArticleId><ArticleId IdType="pmc">PMC10011749</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2023.104507</ArticleId><ArticleId IdType="pii">S2352-3964(23)00072-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos G.C. Systemic lupus erythematosus. N&#xa0;Engl J Med. 2011;365(22):2110&#x2013;2121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner T., Furie R. Novel paradigms in systemic lupus erythematosus. Lancet. 2019;393(10188):2344&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pubmed">31180031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A., Gordon C., Crow M.K., et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2</Citation><ArticleIdList><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussabel D., Quinn C., Shen J., et al. A&#xa0;modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29(1):150&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2727981</ArticleId><ArticleId IdType="pubmed">18631455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiche L., Jourde-Chiche N., Whalen E., et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 2014;66(6):1583&#x2013;1595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157826</ArticleId><ArticleId IdType="pubmed">24644022</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton V.R., Suarez-Fueyo A., Meidan E., Li H., Mizui M., Tsokos G.C. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23(7):615&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650102</ArticleId><ArticleId IdType="pubmed">28623084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">10537110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science. 2000;290(5489):92&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">11021806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">15032595</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney E.F., Lyons P.A., Carr E.J., et al. A&#xa0;CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med. 2010;16(5):586&#x2013;591. 581pp. following 591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3504359</ArticleId><ArticleId IdType="pubmed">20400961</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney E.F., Lee J.C., Jayne D.R., Lyons P.A., Smith K.G. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523(7562):612&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4623162</ArticleId><ArticleId IdType="pubmed">26123020</ArticleId></ArticleIdList></Reference><Reference><Citation>Papalexi E., Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18(1):35&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehar-Belaid D., Hong S., Marches R., et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol. 2020;21(9):1094&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442743</ArticleId><ArticleId IdType="pubmed">32747814</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley I.T., Kaufman K.M., Langefeld C.D., Harley J.B., Kelly J.A. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet. 2009;10(5):285&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737697</ArticleId><ArticleId IdType="pubmed">19337289</ArticleId></ArticleIdList></Reference><Reference><Citation>Omarjee O., Picard C., Frachette C., et al. Monogenic lupus: dissecting heterogeneity. Autoimmun Rev. 2019;18(10)</Citation><ArticleIdList><ArticleId IdType="pubmed">31401343</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld C.D., Ainsworth H.C., Cunninghame Graham D.S., et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Zhang Y., Lin Z., et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun. 2021;12(1):772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Abecasis G.R., Boehnke M., Lin X. Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet. 2014;95(1):5&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4085641</ArticleId><ArticleId IdType="pubmed">24995866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuk O., Schaffner S.F., Samocha K., et al. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci U S A. 2014;111(4):E455&#x2013;E464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3910587</ArticleId><ArticleId IdType="pubmed">24443550</ArticleId></ArticleIdList></Reference><Reference><Citation>Taft J., Markson M., Legarda D., et al. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell. 2021;184(17):4447&#x2013;4463.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380741</ArticleId><ArticleId IdType="pubmed">34363755</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M., Costenbader K., Daikh D., et al. 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lun A.T.L., Riesenfeld S., Andrews T., Dao T.P., Gomes T. Participants in the 1st Human Cell Atlas J, et&#xa0;al. EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 2019;20(1):63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431044</ArticleId><ArticleId IdType="pubmed">30902100</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A., Hoffman P., Smibert P., Papalexi E., Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X., Mao Q., Tang Y., et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764547</ArticleId><ArticleId IdType="pubmed">28825705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Spielmann M., Qiu X., et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566(7745):496&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6434952</ArticleId><ArticleId IdType="pubmed">30787437</ArticleId></ArticleIdList></Reference><Reference><Citation>Aran D., Looney A.P., Liu L., et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6340744</ArticleId><ArticleId IdType="pubmed">30643263</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S., Guerrero-Juarez C.F., Zhang L., et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889871</ArticleId><ArticleId IdType="pubmed">33597522</ArticleId></ArticleIdList></Reference><Reference><Citation>Der E., Suryawanshi H., Morozov P., et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20(7):915&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6584054</ArticleId><ArticleId IdType="pubmed">31110316</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathewson N.D., Ashenberg O., Tirosh I., et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184(5):1281&#x2013;1298.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935772</ArticleId><ArticleId IdType="pubmed">33592174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Wu L., Zhong Y., et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. 2021;184(2):404&#x2013;421.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33357445</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguly D. Do type I interferons link systemic autoimmunities and metabolic Syndrome in a pathogenetic continuum? Trends Immunol. 2018;39(1):28&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">28826817</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau R., Hong S., Cantarel B., et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165(6):1548&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pubmed">27259156</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez R.K., Gordon M.G., Subramaniam M., et al. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science. 2022;376(6589)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297655</ArticleId><ArticleId IdType="pubmed">35389781</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y., Zheng Y., Li D., et al. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. eBioMedicine. 2021;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318865</ArticleId><ArticleId IdType="pubmed">34284174</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M., Fu W., Ranger A., et al. Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus. BMC Med Genomics. 2019;12(1):4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327466</ArticleId><ArticleId IdType="pubmed">30626389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong X., Meng S., Tang D., et al. Single-cell RNA sequencing reveals the expansion of cytotoxic CD4(+) T lymphocytes and a landscape of immune cells in primary sjogren's Syndrome. Front Immunol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884617</ArticleId><ArticleId IdType="pubmed">33603736</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zaslavsky M., Su Y., et al. KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science. 2022;376(6590)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8995031</ArticleId><ArticleId IdType="pubmed">35258337</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaglia M., Merlotti G., De Andrea M., Borgogna C., Cantaluppi V. Viral infections and systemic lupus erythematosus: new players in an old story. Viruses. 2021;13(2):277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7916951</ArticleId><ArticleId IdType="pubmed">33670195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircher M., Witten D.M., Jain P., O'Roak B.J., Cooper G.M., Shendure J. A&#xa0;general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992975</ArticleId><ArticleId IdType="pubmed">24487276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersse K., Verspurten J., Vanden Berghe T., Vandenabeele P. The death-fold superfamily of homotypic interaction motifs. Trends Biochem Sci. 2011;36(10):541&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">21798745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Kaneko N., Nakagita T., Takeda H., Masumoto J. A&#xa0;comprehensive interaction study provides a potential domain interaction network of human death domain superfamily proteins. Cell Death Differ. 2021;28(11):2991&#x2013;3008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564539</ArticleId><ArticleId IdType="pubmed">33993194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware C.F., Croft M., Neil G.A. Realigning the LIGHT signaling network to control dysregulated inflammation. J&#xa0;Exp Med. 2022;219(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130030</ArticleId><ArticleId IdType="pubmed">35604387</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes T.D., Wilson E.B., Black E.V., et al. Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT. Proc Natl Acad Sci U S A. 2014;111(52):E5688&#x2013;E5696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284554</ArticleId><ArticleId IdType="pubmed">25512551</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro-Dominguez D., Martorell-Marugan J., Goldman D., Petri M., Carmona-Saez P., Alarcon-Riquelme M.E. Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression. Arthritis Rheumatol. 2018;70(12):2025&#x2013;2035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326877</ArticleId><ArticleId IdType="pubmed">29938934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogilenko D.A., Shpynov O., Andhey P.S., et al. Comprehensive profiling of an aging immune system reveals clonal GZMK(+) CD8(+) T cells as conserved hallmark of inflammaging. Immunity. 2021;54(1):99&#x2013;115.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33271118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D., Saligrama N., Leventhal O., et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577(7790):399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445078</ArticleId><ArticleId IdType="pubmed">31915375</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wei K., Slowikowski K., et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20(7):928&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602051</ArticleId><ArticleId IdType="pubmed">31061532</ArticleId></ArticleIdList></Reference><Reference><Citation>Piantoni S., Regola F., Zanola A., et al. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes. Lupus. 2018;27(1):143&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">28764616</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritsch R.D., Shen X., Illei G.G., et al. Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum. 2006;54(7):2184&#x2013;2197.</Citation><ArticleIdList><ArticleId IdType="pubmed">16802356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen Y., Chunsong H., Baojun H., et al. Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells. Immunology. 2004;112(2):274&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1782491</ArticleId><ArticleId IdType="pubmed">15147571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel Y., Bauer B., Steinle A. Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex. Front Immunol. 2013;4:362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819593</ArticleId><ArticleId IdType="pubmed">24223577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.L., Lin S.C. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients. Clin Exp Med. 2017;17(1):101&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">26590595</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y., Lim J., Kim S.Y., Kwon G.C., Koo S.H., Kim J. Changes of frequency and expression level of CD161 in CD8(+) T cells and natural killer T cells in peripheral blood of patients with systemic lupus erythematosus. Microbiol Immunol. 2020;64(7):532&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">32343447</ArticleId></ArticleIdList></Reference><Reference><Citation>Konduri V., Oyewole-Said D., Vazquez-Perez J., et al. CD8(+)CD161(+) T-cells: cytotoxic memory cells with high therapeutic potential. Front Immunol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7882609</ArticleId><ArticleId IdType="pubmed">33597948</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol. 2016;12(3):169&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5314913</ArticleId><ArticleId IdType="pubmed">26698023</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng H., Chi H. mTOR signaling in the differentiation and function of regulatory and effector T cells. Curr Opin Immunol. 2017;46:103&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554750</ArticleId><ArticleId IdType="pubmed">28535458</ArticleId></ArticleIdList></Reference><Reference><Citation>Caza T., Wijewardena C., Al-Rabadi L., Perl A. Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis. Transl Res. 2022;245:55&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240418</ArticleId><ArticleId IdType="pubmed">35288362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Z.W., Kelly R., Winans T., et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. Lancet. 2018;391(10126):1186&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891154</ArticleId><ArticleId IdType="pubmed">29551338</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol. 2012;12(5):325&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3417069</ArticleId><ArticleId IdType="pubmed">22517423</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilly G., Doan-Ngoc T.M., Yap M., et al. IL-15 harnesses pro-inflammatory function of TEMRA CD8 in kidney-transplant recipients. Front Immunol. 2017;8:778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5492498</ArticleId><ArticleId IdType="pubmed">28713392</ArticleId></ArticleIdList></Reference><Reference><Citation>Doan Ngoc T.M., Tilly G., Danger R., et al. Effector memory-expressing CD45RA (TEMRA) CD8(+) T cells from kidney transplant recipients exhibit enhanced purinergic P2X4 receptor-dependent proinflammatory and migratory responses. J&#xa0;Am Soc Nephrol. 2022;33(12):2211&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9731633</ArticleId><ArticleId IdType="pubmed">36280286</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>